<SEC-DOCUMENT>0001171843-20-006570.txt : 20200922
<SEC-HEADER>0001171843-20-006570.hdr.sgml : 20200922
<ACCEPTANCE-DATETIME>20200922161508
ACCESSION NUMBER:		0001171843-20-006570
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200922
FILED AS OF DATE:		20200922
DATE AS OF CHANGE:		20200922

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Genfit S.A.
		CENTRAL INDEX KEY:			0001757064
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38844
		FILM NUMBER:		201189722

	BUSINESS ADDRESS:	
		STREET 1:		PARC EURASANTE
		STREET 2:		885, AVENUE EUGENE AVINEE
		CITY:			LOOS
		STATE:			I0
		ZIP:			59120
		BUSINESS PHONE:		33 3 20 16 4000

	MAIL ADDRESS:	
		STREET 1:		PARC EURASANTE
		STREET 2:		885, AVENUE EUGENE AVINEE
		CITY:			LOOS
		STATE:			I0
		ZIP:			59120
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>f6k_092220.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES </B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 6-K </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>REPORT
OF FOREIGN PRIVATE ISSUER </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>PURSUANT
TO RULE 13a-16 OR 15d-16 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>UNDER
THE SECURITIES EXCHANGE ACT OF 1934</B></FONT><B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Date of report: September 22,
2020</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commission File Number: 001-38844 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>GENFIT S.A. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Translation of registrant&rsquo;s name
into English) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Parc Eurasant&eacute;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>885, avenue Eug&egrave;ne Avin&eacute;e</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>59120 Loos, France</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>(Address
of principal executive office)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 20%; text-align: left">&#9746; Form 20-F</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 79%; text-align: left">&#9744; Form 40-F</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; padding-top: 12pt; padding-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT LIST </B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 4%">&nbsp;</TD>
    <TD STYLE="width: 90%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: black 1pt solid"><B>Exhibit</B></P></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: black 1pt solid"><B>Description</B></P></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><A HREF="exh_991.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="exh_991.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press
    Release dated September 22, 2020.</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; padding-top: 12pt; padding-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="4" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GENFIT S.A.</B></FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    September 22, 2020</FONT></TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: top; width: 26%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Pascal PRIGENT</FONT></TD>
    <TD STYLE="vertical-align: top; width: 19%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Pascal PRIGENT</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exh_991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="logo.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: #005478"><FONT STYLE="font-size: 14pt"><B>GENFIT To Announce First Half-Year 2020 Financial Results and New Corporate Strategy on September 30, 2020</B></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 38.4pt; margin-bottom: 0pt; color: #005478"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 38.4pt; margin-bottom: 0pt; color: #005478"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #005278"><B>Lille,
France; Cambridge, M.A.; September 22, 2020 </B></FONT>- <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>GENFIT (Nasdaq
and Euronext: GNFT)</B></FONT>, a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic
and liver diseases, will announce its first half-year 2020 financial results and new corporate strategy following market close
on Wednesday, September 30, 2020. The press release will be followed by two conference calls hosted by GENFIT management to discuss
the results and new strategy:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>Conference Call in English
on September 30, 2020 at 4:30pm EDT / 22:30 CEST, and in French on October 1, 2020 at 1:30am EDT / 07:30am CEST</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="color: Black">Both the English
and French conference calls will be accessible on the investor page of our website, under the events section at https://ir.genfit.com/
or by calling 877-407-9167 (toll-free U.S. and Canada), 201-493-6754 (international) or 0 800 912 848 (France) five minutes prior
to the start time (no passcode needed). A replay will be available shortly after the call.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; color: #005478"><B>ABOUT GENFIT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="color: Black">GENFIT is a late-stage
biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases. GENFIT is a pioneer
in the field of nuclear receptor-based drug discovery, with a rich history and strong scientific heritage spanning more than two
decades. GENFIT plans to initiate a Phase 3 clinical trial of elafibranor in patients with PBC. As part of GENFIT&rsquo;s comprehensive
approach to clinical management of patients with liver disease, the Company is also developing NIS4&trade;, a new, non-invasive
blood-based diagnostic technology which, if approved, could enable easier identification of patients with at-risk NASH. With facilities
in Lille and Paris, France, and Cambridge, MA, USA, the Company has approximately 200 employees. GENFIT is a publicly traded company
listed on the Nasdaq Global Select Market and on compartment B of Euronext&rsquo;s regulated market in Paris (Nasdaq and Euronext:
GNFT). www.genfit.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; color: #005478"><B>GENFIT CONTACT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; color: #005478"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>GENFIT
</B></FONT>| Investors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Naomi EICHENBAUM &ndash; Investor Relations | Tel:
+1 (617) 714 5252 | investors@genfit.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PRESS
RELATIONS </B></FONT>| Media</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">H&eacute;l&egrave;ne LAVIN &ndash; Press
Relations | Tel: +3 33 2016 <FONT STYLE="color: Black">4000 | helene.lavin@genfit.com</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 38.4pt; margin-bottom: 0pt; color: #005478"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 38.4pt; margin-bottom: 0pt; color: #005478"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 38.4pt; margin-bottom: 0pt; color: #005478"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 90%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt; color: rgb(112,111,97)"><FONT STYLE="font-size: 9pt"><B>GENFIT
                           </B>| 885 Avenue Eug&egrave;ne Avin&eacute;e, 59120 Loos - FRANCE | +333 2016 4000 | www.genfit.com</FONT></P>



</TD>
    <TD STYLE="text-align: right; width: 10%"><FONT STYLE="font-size: 9pt; color: #706F61">1</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #" P\# 2(  A$! Q$!_\0
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M':=AAIWW#_=' _K7GY-!RQ::Z79Z.:34<,T^MC:N[RWT^SEN[J58H(E+N[=
M*XF7XO\ AJ.0JL=_*!_$D*X/YL#6G\2,_P#" :K_ +L?_HQ:^=AU%??8:A"I
M%RD?"XS%5*,U&!] +\3-.90RZ+KI4C((LQ@_^/4C?$K3P,G1== '<V8_^*KJ
M;VX>UT.XN(L;XK9G7/3(7(KQ'_A;?B?^_9_]^/\ Z]32I*I?ECMY_P# +K5Y
M4;*4M_)?YGLFMZ]::%HIU:Y2:6V&W/DJ"V&Z'!(]17*#XP^'.GV74O\ OTG_
M ,74'BB^N=3^#0O[QU>>X6*1BJ[0,R#@"O%8\^:FW&=PQFM:&'A*+YNC,,3B
MZD))0V:OL>_?\+*L/^@)KW_@&/\ XJM71?%=IKJW?D65_ ]L@=H[F$1LX.?N
M\\]/U%9GV;XC?]!#0_\ OV_^%;&B1^(([*\_X2">TEE)_=&V& %QSG@=ZPE&
M%M/S_P" =4)5'+6_W)?J<O\ \+A\.D9^RZEC_KDG_P 75S2?B;X?U?4HK&/[
M5;R2G"-<(JJ3V&0QY-<-\+=%LM?@UVPOXM\3Q18/=#EL,#V(KEO%'A>]\*ZJ
MUK<@M$WS03@8$B_T/J*Z50I.3AU.)XFNH*H[-/R/H^XE^SVTLQ1G$:%RJXR<
M#.!FL'PUXRT_Q5)<+8072"  NTRJHYS@##'T-<;X*^((O-+FT;5Y?])6%A;S
ML?\ 6#:?E)_O>A[_ %ZQ?!@X;6/I%_[-63H\L9<VZ.A8GGG!0V=[F]<?%G0;
M6YEMY;741)$Y1@(DZ@X/\=2P?%'2KF/?!I>LRIG&Z.V##/U#5XKKO_(P:E_U
M]2?^A&N_\ )XJ;PZW]BW6GQ6OGME;A&+;L#/0=.E;3H4XQYOU.>GBJLYN/Y+
M_@G:6OQ"L+J\@MO[+U>$S2",236H5%)..3NZ4[7_ (A:5X;U1M/OK>],H0.&
MB12I!^K"F:?'XV74[=M0O-,>R#?OEA0AB,'ID>N*\W^+)SXS!_Z=8_YFLJ=.
M$Y\OZFU6M4ITN;K?JO\ @GIWA[QWIGBB]DM;&"[1HHS(S3(JJ!D#LQ]:HM\1
MM/W-MTG6I%!(#I: J?<?-TKC?@W_ ,C!J'_7K_[.*]CE_P!6WT-35C"G-QM^
M)="=2K34KV?H<$/B[X>'6VU'_OTG_P 75R'XG:7/$)8=)UJ2,]&2U# _B&KP
MB7_7/_O&O?\ X9?\B#IWUE_]&-5UZ-.G'FM^)CA<16K3<;V^1TFCZG!K.F17
MUNDJ1R9^25=KJ0<$$=NE7L4 TI-<#WT/55[:C2*:W2E+4UFXH0F ;FJFKN%T
MJ8G_ &?_ $(5,7&:R_$4XCT&Y8GIL_\ 0A6J1F]C!>XR,"FJ":S[>X63!S6K
M"HZDYI5)6)BG(54(&::Z''-3[N,5"[X%9>T-O8W159<4TDXJ1B&/O3>^#6E.
M9C.#B-5F!XJPDS 5"",T\$8KIW1F3"4D@5=@7-9R,-W-7[>1?6N:O-Q0XZNQ
M,'%(9!6<;D#O2K< ]ZV:L%RZ7J-GJ)7W=Z7@TDRV-8YJ+;S4QQ3>*K0D0"IX
MQ40IZMBAH5RQ_#4$HJ4-E>M1N:FQ5RA,A8&N2\0VVZ-L#)/0"NSD P2> !D_
M2N0O]8@NM52U@8+&&_>3;<[1[>])NQ25S)L-*CM%CN-07#.?W:$XW&NF\2/J
MDOAB&VTV"T2,_.YF95)/IM-<EXC\5K<ZNEFM@RK;$?9C)][_ 'L>]8?BNWO(
M--%_J&M![V<_N[2,D[5]S6=^Y:1OW&G:Y<P6MGJ3K!!-@331L-FP>F#7&^*H
MM*EO4M] M)RD?#RA23(?7BJ%MK5\NFLC7,C1@'"DGBH+/6=5A(CMI"&]$7)H
M'HT2P37-C;M$3+&,9*-E3^5+IWBG5]*41VESM09(&W-6E\1+>(UKKEN)QTWJ
M-KH?ZTEE96FGZE%>1R+>6P.Y4;@CZT[B2)T\5"^;R-=M5DC<?>5-KK[BJ3:/
M$EW%-%<>?8,^<@_,H]"*H:YJ#:CJDMP4"J3A55< "HK&5XE9MQ"_W:0S5\53
MZ=-J"1Z;:B"W10-IZYK.T^^N('*)*VP]5SQ4<5\ID8S0JY8DD&M*SCTR[1D4
MFVF;A6)RN:8%>XOH+F<BY5MJC *GH*NZ?I%C?%EMM06.0#,<<HP&]LUC7-E<
M64_ES("<_*X&0]:&HZ8NEZ=9W0N/]*F^8HIX44"7F5-1@GMKUH[F)HY!QR>O
MT-7-._M:S@DU'3WFBCBZRJ<#/]:C35Q/#]GOD$R8X8_>'XU?>_N/[%&EV\B"
MW=MQC/'ZTMBD3W/B"/7X0-7B47H^Y=!<$^Q]:VM.ATFT\$WHN[=+F_D;$+]=
MGTKAIK"]C(\R!M@/!'(J9[Z2W18XW*E.?;- F/LY;JPD$\#$,/O(W&1^-=YI
M/BR*WT&72S'%:K>$AY&7@9[UR^F^+'M_W-_I]O=0M]X%<,/QJ?5;;3M4C%QI
M!8!1DVSGG\#0!NZ/X=US3I1'INI0W5I,PQ);3[2I]<<5VGBV*U=;/3S,\]]%
MA&N)%P-WN?2O,O#GAS5=5MKR]T^\^S):#+!B<DCM5C3_ !;J,RR(\RF]0?+O
M&1)CUIW%8T[BTDM9#',H#8SP00?Q%0; #6\TEQJ'AR&2\TG[+--)FWN ?DD]
ML=JPIH9X)&BEC9) >5-.Y(Y<=Z&4&JY+=J=$))9%0=2<4 7+33&NY,*.!U-;
M5MX75B"P!KH=$T=;>S3(^8C)K?AM  ,**:T$<S:^'8XL$ 5N6EEY?!%:B6HS
M4_D  4^:Q$D0Q0 #I5F*+YA0H_*IH^&%+G)0YTX-495'I6FX..G6J4P JKEW
M*##&?2N7U9_LMUD<*:ZQQ@$UR7B09(QVJHLF1+8WZ-*!NKK;.3<%->56\KQ7
M(()KO-)O=T*Y:LJQ5-ZG7)( *TK)LPD_[58$,NX#FMK3VS;G_>_H*QB]3H:+
MM)29H)JR1::32$TPM3L(DS7(^(OAYHGB34_[0NS<13E K&%PH;'0G(//:NI+
M50U6U@NK.5I80[QQL4/<'%$ISIQ<H;B]G"HU&>QQ_P#PIWPY_P _&H?]_5_^
M)I?^%.>'/^?C4/\ OZO_ ,36VD(L?#<,]LC0SO'%YKH#NP2-W]:GM[D'5;6.
MVO+F>-@_FB3) P..P[UBLQJ7BI;NW7O\M?,MY;1U<4K*_3M\_N(]*\%:7HUK
M'!:O<;8R6!=P23G/I]/R^M2W7A.QO)S---<%CQPPP!Z=*A:\U.!W!\QX[%RT
MAQDS(QXQ[@']*M33WL.F6\($LE[<<L4 )C!Y;&>. <"N:M5HXE/VT&[=_N_/
M3\=CIHTJF'LJ,DK]OZ[:E7_A"=,_YZ7/_?8_PKH$C2*)8XU"H@"J!V K#:^O
M?[!NXV6:.]M\ $C#,"1AN.,XZT^P:\76&AG,R(L9)667>'/&"IP.G-11="E)
M*E3MS6_71^EF:U56J1;J3O:_Z;?>:=Y9V]_9RVEU$LL$RE71NA%<1+\(?#<D
MA9'OHU/\*R@@?F":U8;R<Z>CQ7=U)J.[_4E25/S=",<#'O5K5;F>/4BJW+)&
M(UP@=DYR<G(4Y[5K#,7"'-&_3JNO]:F-3+XSERSL]^G8R#\,-,:(Q-JVLF,C
M:4-UQCTQBJW_  IWPY_S\:A_W]7_ .)KM=+E>;3+>23?O9>=_7\>!6-KJJ=<
MA,HC\O[.>98V=<[O]GO6]3'5*=)5$][?B<\,!1G4<&EI?\/F2W'A"QNO"D?A
MV2XN?L<>T!@R[R%.0,XQ^G:N>'P=\.]KC4,_]=5_^)K8LWE@T357M]RL')B:
M-2J_='W0>:NZ5,)]Z/>3-*5(VB0L ..>5&#4TLPDW&*T<M=_-K]"JN7T]9.S
MY=-O)?YF/_PK2P_Z#.M_^!?_ -:M/1?!]GH<ES+#>W\\L\7E;[B;>4'^SQ]/
MRJQ90S-?WB27=T8XG41@OP05R>W/)I;.&;^UKI'N[IHH?+*!GX.02<\<U?UN
MI)*Z>KMNNGR\B?J=*+;36BOUZ_/S*?AGP5IOA2>XET^:Y;SU"NLK CCH> /4
MUH:]H-AXBTUK'4(MT9.59>&0^JGL:S8KN1M1N%NKN:-%G8*%=@<=N-N,?C4F
MH2WPO[PQ+</#$B$+%)MQD')Q@YK+^T+KVEG>]O/K_D:K )?N]+6^73_,YT_"
M#P\.EQ?_ /?U?_B:W?#?@_3O"IN?L$EP_P!HV[_-8'&,XQ@#UK;T_P QM.MS
M+())"@W..YK*O8KM==EN;4,S10(3%VD!+9'UZ8KHJXR:IJ3NT[:?C^!A2P5/
MVC2LFKZ_A^)SES\*M#N;F6>2XOC)*Y=CYB\DG)_AKH/#WAVU\-V#6=G),\32
M&3]Z02"0!V ]*?80W2ZW</=$F22V5R!]U#N/RCZ#%5]'N&F:/[5=2B0GA=[<
MG/0C;@?G67]H2E:,D]6]_*W^9HLOA!N4+:);>?\ PQN@5RVO> -*\1:FU_>S
MW8E*A,1NH4 ?A5M[@A[[S+RZ2=)6$,: D$8&.,<\U?BDNC?V*R[EWV[-*H'&
M[Y?_ *]%+&^][J_J]OEM]PZN#3C:6J_X%_U,OPYX&TWPQ?27=C-=,\D?ELLK
M@@C(/8#TKI7C,B,N2,@C(ZBL"UN=T4337UV+LS8:)5R/OXQC'3%7YYKE3K.U
MG'E1*8<#H=A/'XU/U[G7.U^79O\ 0I8+V?N1T_X=+]3E#\(- ))-Q?Y/_31?
M_B:Z[0=#M_#^E1Z=:R2O!&6*F4@D9.2. .Y-0"XU**:QM[A68/*I\^,<.NTY
M##L>E0/=2?VO=QW-U-%"LF%VNPP-HZ *0>?>E4S%R5I7WMKITN%/+XP=XVVZ
M>MCHAQ032@#:,'(QUII%;$#&-1.W%/>J[YS5(EB=3FL?Q4"?#5V!_L?^AK6P
M :S?$2;M N1[I_Z&M:(S9Q%A$RJ,UMP;L"JEM'A0,5IPQ\5RU&=-&"0X U%(
MA(JV$IDJ +6-SI449Q!4TUSW%2R#BHRORUK3;N<^(BBN92#UH,KD=:1X_FIZ
MID5Z4=CSWN0>8X;K5RWF(ZFJLD7I4\$1)KGQ,;H=-/F*0F)8\U9B?CDUGAP"
M2:6.<LV!2J3L:TZ;D;4<HQ4RMD=:SXF)%6HSS6*JG2Z.A*S$4SS#FI1AA[U&
MZ8KIA*YRSC8>) U+NJN,@T\$XK=F&Q95Q1N))].Y/856!8$>]<WXO\2+I=K]
MC@;-U+\O^[FH9:U(==\0F\OTTC3R!WEDSC"CJ2?2L#5=>TO1=:%WISK=N$54
M5%^56[_6J]MIEN9)TEOS'YL?S<X:1O<]A619%-!NY(':W-ZW!F/*Q#MCUXK'
M<V6A+<^-EU*:9KK383=+]V8K\Z?6N=37U2>21[6.:1CPT@W8^E:__"/Z?J"2
M26&NQ/=,3F.X4KD^QJI9RPZ!97D4UM'+>R#9O'('TH!A<:UI6LJ([NS6SEQM
M6> 8'XKTI-.:/PY=RSQO#=,4(20#( _QKF9(Y%;+Q2(2>I3 -333LD 13R><
MF@:=AEY-)<74EPZL#(=Q..M/BD,%JQ!Y/0"I8=3E$8C(5D]QQ5\_V?JUJ(R?
MLUVOW6'W6H RH=0:/@JK#OD5K0/I6HVQMY!]DN#]R1?NGZU!IUC'9:GG4 KQ
MQ_,-O(:LR\G$M[+*@"*6+*H[>U RX-'GM[Z**X \MCGS%.01]:=KGV--2VZ<
MA$"*!SW;UJ.VNY1$6D);;]T$TP26L[9F4J3_ !+2%<EM=1G<"WE;>F>,C)'T
MIURT-W*$,I0CC!Y%3QZ6K6\DEE.)6QRC<'\*Q721'VLK*XZANM,$:L.AW3KY
ML++.@Y.PY/Y5GS3$S$9*LAP16B]K?Z-':W4DFSSQNC4'H*+B[M=44&= EST#
MJ/O?6D!)INJ:G81M.@9[4?*X<97]:+B.TU5C/;A8)CRR9^5JL7UU<OH4.EPQ
M@PQ-N.W@GZU@B*6.4*\;+[E2*!LZ'3TM;#0[Z6ZBWW3KLB)Y"^]8D-Q) RR0
M.0V>"*M2:B\&Q0%<*.0W2KT%[HUV=M[9F)R.)(CTH!ZE_3O$$MGI\D,DCQI.
MWSE.#]:GA\,:?J<4<^CZ_%YP(S%/\A_/BL/4[3RBLL$AGM<?*>X^M+I&DS7\
M%U<Q3^4+:/<3G&: N>C^(=?BFCM?#\]Y]C2! 4D RK..]:%WI<MSX9MKZ2_@
MO)U?9E ,X[9(ZUY9#J*7\#6E_P G/[N4]0?\*[6UT>X\/^%;/65NC<03L5GM
MW. ,'@BFA,@,14D$8(ZCWJ]H]L'OH\XX-.U)[>X6.\M+::"-U!>-QT;U'J#4
MF@RJ-0CSW--$L]0LX1Y:G';%7T0 =JK6KCR@.*N)@T-B'A0>U*R@+3TP.M-F
M;/%9R=A,B& *-^*A>3!J!Y3CK63J6,VS2\T%>M5IF!K.>Y9>AIIN78=:UIS3
M)<K$\[A8RU<IJ*&X<DUO3LSKR:S9H_6NN*&I71RTT'EMNJ]8ZD(&"DXQ3[^(
M*AK";<&S14CS($['I-C?B1%(;]:ZS2)?,M&/^V?Y"O'M/U&2W&,G%>D^$K[[
M5I,CYZ3$?^.K7)R-,WC.YT^ZFEJ@\S-.#520[DA--HI<50AII*=BC%  !3PM
M*JU*!0 P)3@M/Q2XI#(\4A%2$4TB@9"PIM2,*94M#3%%+BA13\4["9"X-1\Y
MJR5S4;+BF(8*<*0#FI *BY=A!FEQ2XI<4(30WI013B.*3%6B1N*0BG4&F!&1
M0!3C2 4@'"E%)BG 5#*08I<4N*7% QA%-*U-BFD46"Y 4J-HQ5D]*B84T2V0
M;:S=?7_B27'_  '_ -"%:QK,U[G1;C_@/_H0JA'*0 8%7XCQ6?#D5<C; KDF
M=U*+9<4TDA^6FJXQ37?(K&YT\K*\F*KEL9XJ25C59G(K>D<M>.A&\HS4L1##
MI5$MNDQ6A;+D"O17PGEOXB9+?><U:2 (,8J:"/ SBIME<M61U4HG"OTQ3[="
M'J(MDU8A8"HGJ:T]$:< &*F/RFJBR8'%#SFL%&S-T[EU)>:>SYK,CN<-@U9$
MX-=--G-51/WJ1 6XJ-#NJ96["NI,XFM2IJM]%I.FR7<Q&5!"^YKQB?67N-6.
MIS@2R DQ1,,@MZXKH?B)KS7E^FG6QRJ'9@=VKF_,M=+=XKG<9U3:'B/*GTS4
M29I&-M3,U"XN9D>]N;@QO(WR)W;\/2JT$(OF::YEVQ(.>>6/I5FSUI;2:23[
M-%/)GK*NX ?C46IZI'>7"RBW2&,XW1QC ^M06S*\P?:<(QP#Z]*FN+N19(V+
M98=ZUH]2T8QLDNDH<GB56^854N=*BN$-Q8W22IWC;AE_.@$B0>)KR=$2Y,<T
M:_PM&.GUIUU:Z=JR^;92BVG YB?[I^E5;IH(--6&-!YC<EJS$8^8 IP"?6@9
MKV2QZ=;SF:,/(1M'<?A6,7(.X'!)SBKLUSL"( ,#D\=:DMYK*1\SPY!/.T\_
MA0(9]J:*V&\Y)]:=#)92G_28,@]U.*LWND":$3V$HFB[Q_Q+4&EV,,K2M>$Q
MJBG ]30,L3Z8)[4MIS^8%^]&?O5G6-H]S>);MF/+8<D=!ZTQ+F6V<.C,,?=_
MV:TDO?/'GRX5@,%@.30!!>_\2O47BM;AG1#Q(.]3"_CO]HGA4R _ZSH:KFS%
MRY:&=23V8XI#8W%C&TDT?T8<C\Z +5^)]1*%9@XB&U5)Z?2J2V5Q;/OG@>-?
M7'!_&JJN^X$'))K:CU6\MXQ:7ZO)%_SSDYX_&D%S-:\E\XNKG'UK6L]<FCB$
M=U$LT#?WE_D:J7-G:SXDLY-N3S&:LZQ=C^RK.QCB"K%DE@O4GWH8(BO[&"8M
M<6#9C;DQD\BK1M["W\,&24'^T'<;<] O^<5A0,YF"JV![&M-]3C#B*6)9$Z<
MT6&F5K:_FMN 0RGJIZ5LV<L)LS;&X%J9_O$=*;!;Z!?1ED::VN1_">5-9M_!
M/!<E)1A?X"#P10@L;G_"$7UQ&LUI<VUU$#AO+;# 5?G\0Q)"-$O_ #);-%"A
M <;6'<5SEE:W\6GR:E"Q6"%PI]S4MQ<QZQ:$LJ+=)U;NX]Z8CV.VN+3Q/I6F
MV&G7$4<42;&FEQN/'0URYM9M)U@P2=4?&1WJI?Z#;:3<Z+'9730)J4:JX.3Y
M<GK6YJ]K<P'^S[Q&^WVRAEN%4[)E/?/K1<EG>Z9=":VC(/:M5),#K7FV@:\(
MPL<AP*[.VU!)$#!ABIDS-RL;HFXJ*6;WYK/-ZH'!YI\3-*V3TK*3N0Y$^"YS
M0T)QS5N*+@5,8\#FL^2Y:1AS0\]*B'!Q6Q/$I!P*RY(]KYH@G&1-2.A%)TJE
M(,FK<[X%5>&->G3V,H&;=P;QR*RI;'C@5TLD6X56:WSVJV6<W]G*#I7?>!<C
M1)P?^?EO_05KGVM <\5U?A&'R])G'_3PQ_\ '5K*:T+AN;JL:G0U7/!J5&K(
MU+(IP%1J:DS0 4H&:;FL9KWQ*)&$>B6#H"0K'4""1V./*XII7$Y6.@44\"N?
M%]XI_P"@#I__ (,F_P#C5.^W^*?^@#I__@S;_P"-4<K_ *8N==G]QT%%8'V_
MQ5_T -/_ /!FW_QJC[?XJ_Z &G?^#-O_ (U1RO\ IA[1=G]S-_%-(K"^W^*O
M^@#IW_@S;_XU2?;_ !3_ - '3_\ P9M_\:HY7_3#VB[/[C;85'MYK&-]XI_Z
M .G_ /@R;_XU2?;O%.?^0#I__@R;_P"-4<K_ *8>T79_<;P6G8K %_XI_P"@
M#I__ (,F_P#C5.^W^*?^@#I__@S;_P"-4<C_ *8>T79_<;I%,9:Q/MWBG_H
MZ?\ ^#)O_C5--_XH_P"@#I__ (,F_P#C5'(_Z8>T79_<;!&#3Q6";[Q1_P!
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M..34Z#BJT3;CFK24@)!3L4@IU( I*6FF@89HS244Q :2@FF[J '4N:9NI=U
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MKSV]Z]7U/P]I6K6$=C>6:/;Q?ZM%)39QCC&,5DV/P[\-V5RLZ6)D=3E1-(6
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MI1Y:,,A@.E $1ADC(,BD#U'-.N'SA?;H:GBF=T#/P!Z5)+<PW2!'1 XZ$=:
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M>J\)._KWHHH0'0Z0[D[2S%?3/%9FJHJW(VJ!\W8444+<"74N+&W X&*S8?\
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M0=:**8AZU*M%%(!PIU%% Q:***0!1110,*#110(2BBBF M(:** &FHVZ444
M0/3%HHJ)%1)5J&__ ./&3\/YBBBHELS2/Q(Y^7O38/\ 6445S+<ZI;&U;?=%
M6QTHHKJ6QQO<0]*KR@444F-&;.HW'@5 JC=T'Y445GU-31MQTK3C^[115P,I
$[G__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
